Background. Prophylactic central neck dissection (pCND) at the time of the total thyroidectomy (TT) remains controversial in clinically nodal-negative (cN0) papillary thyroid carcinoma. Our study was designed to examine the predictive factors and pattern of locoregional recurrence (LRR) after pCND in the context of the postoperative stimulated Tg (sTg) level. Methods. A total of 341 patients who underwent TT and unilateral pCND were analyzed. Patients with an identifiable lesion on ultrasonography or whole-body scan within 6 months of surgery were excluded. LRR was defined as an identifiable lesion on USG, which was later confirmed by cytology/histology. Preablation sTg level was taken 2 months after surgery, whereas postablation sTg level was taken 8 months after surgery. Cox regression was used in the univariate and multivariate analyses to identify significant independent factors for LRR. Results. After a follow-up of 66.6 ± 38.6 months, 14 (4.1 %) suffered from LRR. The duration to first LRR was 36.4 ± 21.7 months. The estimated 5-and 10-year LRR rates were 5.1 and 6.1 %, respectively. Of these 14 LRR, 3 (21.4 %) involved the central compartment alone, 9 (64.3 %) involved the lateral compartment alone, and 2 (14.3 %) involved both central and lateral compartments. After adjusting for other clinicopathological factors, postablation sTg level C 1 lg/L (hazard ratio 265.109, 95 % confidence interval 1.132-62075.644, p = 0.045) was the only independent predictor of LRR. Conclusions. Annualized risk of LRR after pCND was approximately 1 % in the first 5 years and 0.2 % in the subsequent 5 years. Most (78.6 %) LRRs involved the lateral compartment. Postablation sTg C 1 lg/L significantly predicted risk of LRR.
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Papillary thyroid carcinoma (PTC) is the most common type of thyroid carcinoma with an age-adjusted incidence doubled over the past 20 years. 1, 2 Despite its relatively good prognosis, locoregional recurrence (LRR) is common. 3 With recognition of the concept of step-wise progression of nodal metastasis from the central (level VI) to the lateral compartment (levels II-V) and preoperative ultrasonography (USG) only identifies roughly half of the central nodal metastasis (CNM), routine prophylactic central neck dissection (pCND) at the time of the total thyroidectomy (TT) has been advocated. [4] [5] [6] However, this remains controversial in clinically nodal-negative (cN0) PTC. 7 Although pCND may reduce of LRR in the shortterm, it is at the expense of higher morbidity and cost. 8, 9 Despite the increasing number of studies assessing the value of pCND, few studies have focused on evaluating the predictive factors and pattern of short -to medium-term LRR after pCND. Given that pCND is increasingly being performed, a better understanding of these factors and pattern may not only help to assess risk of LRR but also tailor decisions regarding the need for adjuvant therapy (such as radioactive iodine (RAI) ablation, degree of thyrotrophin suppression) and frequency of surveillance after pCND. Although studies have identified clinicopathologic factors predictive of LRR and nodal recurrence after pCND, these factors were not evaluated in the context of the biochemical response after initial operation and RAI ablation. [10] [11] [12] It has been recognized that the biochemical response to treatment (namely, postsurgical thyroglobulin (Tg) levels) is a significant predictor of recurrence in low-risk PTC. 7, [13] [14] [15] In view of these findings, our study examined predictive factors and pattern of LRR in cN0 PTC after pCND in the context of the postoperative sTg level.
PATIENTS AND METHODS

Patients
From July 2003 to June 2013, 351 consecutive patients with cN0 PTC underwent surgery at our institution. To exclude the possibility of residual disease due to inadequate preoperative assessment and/or surgical resection, those with identifiable locoregional disease on USG or post-RAI whole-body scan (WBS) within 6 months of surgery were excluded. Therefore, 341 (97.2 %) patients were eligible for analysis. All postsurgical patients were followed up within 4 weeks in a multidisciplinary oncology clinic. A follow-up visit was conducted at 3-month intervals in the first 2 years, 6-month in the subsequent 3 years, and annually thereafter. Clinical examination, neck USG, and nonstimulated Tg level were done during the follow-up visit. Locoregional recurrence (LRR) was made by a combination of basal Tg trend, USG, CT/MRI, or FDG-PET scan and confirmed by fine needle aspiration cytology (FNAC). LRR was defined as an identifiable lesion on USG, which was later confirmed on FNAC and/or histology. The side and location of LRR was recorded. To ensure complete follow-up data of all 341 patients, a careful manual search of all patients' status in the territorywide Clinical Management System (CMS) was performed. The CMS is a computerized database linking up all public hospitals within our region.
Methods
All relevant clinical, laboratory, radiologic, and perioperative data were collected prospectively, and follow-up data were regularly updated in a computerized database. Details of surgical treatment, criteria for radioactive iodine (RAI) ablation, and follow-up protocol had been described previously. 16, 17 TT was the preferred procedure for PTC C 1 cm. A routine ipsilateral pCND was performed for all regardless of tumor extent. The pCND consisted of the removal of all nodes and fibro-fatty tissue extending vertically from the hyoid bone to the thoracic inlet and laterally from the medial border of common carotid artery to the midline of the trachea. The ipsilateral recurrent laryngeal nerve was mobilized along its entire cervical course. An intraoperative nerve stimulator was used to confirm its functional integrity. 18 Parathyroid autotransplantation was readily performed.
Serum calcium and phosphate levels were measured postoperatively. Calcium ± vitamin D supplements were prescribed if symptomatic or calcium \ 1.7 mmol/L. Those who discontinued supplements in the presence of normocalcemia within 6 months were considered temporary, and those who needed for[6 months were considered permanent hypoparathyroidism. Perioperative direct laryngoscopy was performed to assess vocal cord function. Vocal cord palsy (VCP) lasting [6 months was regarded permanent.
All postoperative Tg levels were measured at the same laboratory using the same immunometric assay. The assay used was the Immulite 2000 (Diagnostic Products Corp. Roche, Los Angeles, CA). This was calibrated against the CRM-457 standard. Normal reference range was \0.5-55 lg/L and sensitivity was\0.2 lg/L. Stimulated Tg (sTg) was defined as a Tg level measured in the presence of TSH [30 lg/L either by thyroxine withdrawal or recombinant TSH injections. The preablation sTg level was taken approximately 2 months after surgery while the postablation level was taken approximately 8 months after surgery (6-7 months after RAI ablation). Tg autoantibodies were measured at the same time, and those with elevated Tg autoantibodies were excluded from Tg analysis. The decision for RAI ablation was based on presence of C1 risk factors, such as tumor size [1.5 cm, CNM, extrathyroidal extension, and microscopic positive margin. Three giga-Becquerels (GBq) or 80 millicuries (mCi) I131 was given as a standard fixed ablative dose.
Statistical Analysis Statistical analysis was performed by
Chi square or Fisher's exact test to compare categorical variables, and Mann-Whitney U was used to compare continuous variables between groups. For correlation between two continuous variables, the Pearson correlation test was performed. Continuous variables were expressed as mean ± SD. LRR rate was estimated using the KaplanMeier method. Variables that were significant in the univariate analysis were entered into multivariate analysis. Cox regression analysis with a variable entrance criterion of 0.05 or less was conducted to identify independent factors. All statistical analyses were performed using SPSS version 18.0 (SPSS, Inc., Chicago, IL).
RESULTS
Our cohort was mostly females (81.5 %) and ethnic Chinese (88.0 %). The mean age at operation was 49.0 ± 14.6 years. The mean (± SD) tumor size was 1.73 ± 1.12 cm. The mean (± SD) total number of CLNs and positives CLNs retrieved after unilateral pCND were 7.2 ± 4.1 and 1.8 ± 2.3, respectively. The incidence of CNM was 22.3 %. In terms of surgical morbidity, 19 (5.6 %) suffered from temporary VCP, whereas 2 (0.6 %) developed permanent VCP. Four (1.2 %) patients developed permanent hypoparathyroidism, whereas 44 (12.9 %) patients suffered from temporary hypoparathyroidism. After a mean follow-up of 66.6 ± 38.6 months, all patients were still alive. There were 14 patients with LRR. Of these 14 LRR, 3 involved the central compartment alone, whereas 9 involved the lateral compartment alone and 2 involved both central and lateral compartments. There were no recurrences in the thyroid bed or tracheal wall. The mean duration to first LRR was 36.4 ± 21.7 months. The estimated 5-and 10-year LRR rates were 5.1 % and 6.1 %, respectively. Table 1 shows a comparison of clinicopathological features between those with LRR (group I) and those without LRR (group II). Extrathyroidal extension, multifocality, and lymphovascular invasion (LVI) and CNM were significantly more common in group I (p \ 0.05). However, among those with tumor multifocality, those with C3 tumor foci were not associated with a higher LRR rate than 2 foci (6/53 vs. 8/62, p = 1.000). Central lymph node ratio (CLNR) was significantly higher in group I than II (72.9 vs. 24.2 %, p = 0.01). Both preablation sTg and postablation sTg levels were significantly higher in group I than II (11.2 vs. 7.5 lg/L, p \ 0.001 and 6.2 vs. 3.8 lg/L, p \ 0.001). Table 2 shows the univariate analysis of LRR using Cox regression. Similar to the direct comparison between groups I and II, tumor multifocality, LVI, CLNR, CNM, preablation sTg, and postablation sTg were significantly associated with rate of LRR. Table 3 shows the multivariate analysis of clinicopathological factors for LRR. Both tumor multifocality (hazard ratio [HR] = 6.783, 95 % confidence interval [CI] = 1.44-31.957, p = 0.015) and CNM (HR = 6.713, 95 % CI = 1.613-27.936, p = 0.009) were independent prognostic predictors for higher LRR. Table 4 shows the multivariate analysis of all factors for LRR. Because preablation sTg and postablation were interrelated, both were entered in a separate Cox-regression for LRR and postablation sTg was the only significant factor of the two (data not shown). Therefore, only five significant factors (not including preablation sTg) were entered into the multivariate analysis. After adjusting for the other four clinicopathological factors, postablation sTg level (HR = 1.027; 95 % CI = 1.001-1.054, p = 0.041) was the only independent predictor. When postablation sTg was entered as a categorical variable (\1, C1 lg/L), HR (95 % CI) became 265.109 (1.132-62075.644; p = 0.045).
After excluding those with Tg autoantibodies, if patients were categorized into three groups based on postablation sTg level (\1 lg/L (n = 216), C1 lg/L but \10 lg/L (n = 67) and C10 lg/L (n = 31)), the 10-year LRR rates were 0, 23.3, and 33.7 %, respectively (p \ 0.001). Figure 1 shows the cumulative LRR curves between these three groups. Table 5 shows a summary of the 14 patients who developed LRR after pCND. None of these patients had detectable Tg autoantibodies. The lowest postablation sTg to develop LRR was 1.1 lg/L and that patient developed LRR 31.7 months after pCND. Nine of the 14 patients with LRR had postablation sTg C 1 lg/L but \10 lg/L and the other 5 patients had postablation sTg C 10 lg/L. There was no significant correlation between CLNR and time to LRR (q = 0.25, p = 0.388) or between postablation sTg and time to LRR (q = 0.041, p = 0.888).
DISCUSSION
This was one of the first studies to evaluate the predictive factors and pattern of cN0 PTC after pCND in the context of postoperative sTg levels. Unlike previous studies, our analysis only analyzed patients with no identifiable lesion on USG and WBS within 6 months of initial operation. Our data showed that the chance of LRR was very low. The 5-and 10-year LRR rates were 5.1 and 6.1 %, respectively. These data implied that the estimated LRR rate for the first 5 years was approximately 1 % per year and dropped to an even lower level (approximately 0.2 % per year) for the subsequent 5 years. Barczynski et al. 19 reported similar results in a large cohort and found the 5-and 10-year LRR rates after bilateral pCND to be 4.3 and 5.5 %, respectively. Kruijff et al. 20 also recently reported similar rates with 5-and 10-year rates of 5 and 8 %, respectively, although their cohort did not comprise entirely cN0 PTC patients. Hartl et al. 21 reported an even lower LRR rate when their 317 patients who underwent both bilateral pCND and prophylactic ipsilateral lateral neck dissection were analyzed. They reported that only two (0.6 %) patients developed LRR after a median follow-up of 4 years. However, given the likelihood of higher morbidity in a disease with an already excellent prognosis, the cost-benefit ratio of routine lateral neck dissection would be questionable. In terms of the pattern of LRR, our data showed that the majority of LRR (11/14 or 78.6 %) were mostly located in the lateral compartment. Of the 14 LRRs, 9 (64.3 %) were solely confined to the lateral compartment, whereas 3 (21.4 %) occurred solely in the central compartment. Kruijff et al. 20 reported that the rate of structural LRR in the lateral compartment almost doubled that of the central compartment after a more liberal use of unilateral pCND at the time of TT (67 vs. 32 %, p \ 0.01). Barczynski et al. 19 reported a higher difference in LRR rate between lateral and central compartments after bilateral pCND (93.8 vs. 6.3 %). In terms of which was the most frequent involved side (relative to that of the primary tumor), the ipsilateral side was significantly more likely as the first site of LRR than contralateral side (72.7 vs. 9.1 %). This finding agrees with previous studies and could be explained by the step-wise progression of nodal metastasis originating from the ipsilateral central to ipsilateral lateral compartment. 4, [10] [11] [12] [18] [19] [20] In fact, because all 14 patients with LRR had at least one CLN containing metastasis (pN1a) at initial operation, we postulate that perhaps some of these patients with LRR might have had small volume of disease in the lateral compartment(s), which was present at initial operation but remained undetectable by USG and WBS in 6 months after surgery. This postulation is supported by the fact that both the preablation sTg and postablation sTg levels were significantly higher in those with than without LRR, and therefore, this implied that there was a small volume of residual disease which was detectable biochemically but not radiologically.
22
In terms of which factors might help to predict LRR, our data found postablation sTg level to be the most significant predictor for LRR. Although previous studies have identified several clinicopathologic factors, such as tumor size, CNM, and CLNR, to be associated with higher LRR, they did not analyze them in the context of postsurgical sTg levels. Several studies, including the 2009 revised American Thyroid Association guidelines, have emphasized the importance of the biochemical response to treatment and found that incorporating it into the traditional risk stratification (or the so-called ''dynamic risk assessment'') could provide a more accurate assessment on recurrence risk. 7, 23, 24 Based on the classification of response to initial therapy 6-24 months after RAI as described by Tuttle et al. 23 , 9 of our 14 LRRs would have been classified as ''acceptable response,'' whereas the other 5 as ''incomplete response.'' According to the same study, half of the latter group would have harbored structurally identifiable disease.
The implications are, first, the biochemical response after treatment remained the most important predictor of LRR after TT and unilateral pCND. Our multivariate analysis (Table 4) confirmed that postablation sTg was most significant among other clinicopathologic factors described in this and other studies. 19, 20 Nevertheless, because postablation sTg is not available before RAI, multifocality and CNM remained important in the decision for RAI (Table 3) . Second, those with postablation sTg \ 1 lg/L had little to no LRR risk, whereas those with postablation sTg C 1 lg/L had significantly higher LRR risk. Perhaps, this higher risk group should undergo longer TSH suppression and more intense surveillance studies, although the real benefits of these measures on recurrence or mortality remain unclear. On the other hand, those with lower risk might require less suppression and surveillance. Third, because 11 (78.6 %) LRR had some lateral compartment involvement, perhaps those patients at-risk of LRR should have more careful follow-up studies on their lateral compartments especially in the first 5 years of surgery. Despite these findings, our data should be interpreted cautiously as this was a moderate-sized retrospective study with relatively short follow-up and few LRR. Furthermore, because all pCND were unilateral, contralateral CNM could not be completely ruled out. Nevertheless, our data only showed a low incidence of LRR (3/14) occurring in the contralateral side. Given the higher morbidity in bilateral pCND, we still believe that unilateral pCND might be more preferable. Another shortcoming was that the few patients with postablation sTg C 1 lg/L might have overly exaggerated the percentages of LRR.
CONCLUSIONS
The incidence of LRR after seemingly curative TT with pCND was approximately 1 % in the first 5 years and 0.2 % in the subsequent 5 years. Of these LRRs, the majority (78.6 %) involved the lateral compartment, whereas the other 21.4 % involved the central compartment only. The postablation sTg was the most significant predictor of LRR with a tendency for higher rate of LRR with postablation sTg levels C 1.0 lg/L.
